Logotype for Byhealth Co Ltd

Byhealth (300146) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Byhealth Co Ltd

Q3 2026 earnings summary

23 Oct, 2026

Executive summary

  • 9M 2026 revenue rose 7.78% YoY to ¥5.298bn; net income attributable to shareholders fell 10.42% to ¥812.7m, while adjusted net income fell 11.93% to ¥728.3m.

  • Strategy focused on growth, digital infrastructure for offline channels, multiple online growth models and accelerating high-potential businesses.

Financial highlights

  • Q3 revenue was ¥1.626bn, up 17.60% YoY; attributable net income was ¥209.6m, up 22.73%, and adjusted net income was ¥171.7m, up 28.65%.

  • 9M operating profit was ¥1.031bn versus ¥1.135bn a year earlier; net income was ¥826.8m versus ¥944.3m.

  • 9M R&D expense increased 44.79% to ¥80.1m; financial expenses were ¥8.6m versus income of ¥14.1m a year earlier, reflecting lower deposit interest income and higher FX losses.

Segment performance

  • 9M brand revenue: core brand ¥2.789bn, up 4.24%; JIANLIGUO ¥579m, up 0.88%; lifespace ¥1.073bn, up 13.52%.

  • 9M offline revenue was ¥2.414bn, down 2.16%; online revenue was ¥2.860bn, up 19.79%.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Byhealth